Jundishapur Journal of Microbiology

Published by: Kowsar

In Vitro Antimicrobial Activity of Dermcidin-1L Against Extensively-Drug-Resistant and Pandrug-Resistant Acinetobacter baumannii

Zahra Farshadzadeh 1 , Mohammad Hossein Modaresi 2 , Behrouz Taheri 3 , Sara Rahimi 1 and Abbas Bahador 1 , *
Authors Information
1 Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2017, 10 (5); e13201
  • Published Online: May 20, 2017
  • Article Type: Research Article
  • Received: January 11, 2017
  • Revised: March 11, 2017
  • Accepted: May 1, 2017
  • DOI: 10.5812/jjm.13201

To Cite: Farshadzadeh Z, Modaresi M H, Taheri B, Rahimi S, Bahador A. In Vitro Antimicrobial Activity of Dermcidin-1L Against Extensively-Drug-Resistant and Pandrug-Resistant Acinetobacter baumannii, Jundishapur J Microbiol. 2017 ; 10(5):e13201. doi: 10.5812/jjm.13201.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Dally S, Lemuth K, Kaase M, Rupp S, Knabbe C, Weile J. DNA microarray for genotyping antibiotic resistance determinants in Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2013; 57(10): 4761-8[DOI][PubMed]
  • 2. Tao L, Zhou J, Gong Y, Liu W, Long T, Huang X, et al. Risk factors for central line-associated bloodstream infection in patients with major burns and the efficacy of the topical application of mupirocin at the central venous catheter exit site. Burns. 2015; 41(8): 1831-8[DOI][PubMed]
  • 3. Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, et al. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2014; 58(3): 1622-9[DOI][PubMed]
  • 4. Roca I, Espinal P, Vila-Farres X, Vila J. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol. 2012; 3: 148[DOI][PubMed]
  • 5. Wang L, Wang YJ, Liu YY, Li H, Guo LX, Liu ZH, et al. In vitro potential of Lycosin-I as an alternative antimicrobial drug for treatment of multidrug-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014; 58(11): 6999-7002[DOI][PubMed]
  • 6. Song C, Weichbrodt C, Salnikov ES, Dynowski M, Forsberg BO, Bechinger B, et al. Crystal structure and functional mechanism of a human antimicrobial membrane channel. Proc Natl Acad Sci U S A. 2013; 110(12): 4586-91[DOI][PubMed]
  • 7. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol. 2010; 48(12): 4592-4[DOI][PubMed]
  • 8. Performance standards for antimicrobial susceptibility testing: twenty fourth informational supplement M100-S25. 2015;
  • 9. Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D, Haghighi MA, et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol. 2015; 6: 1146[DOI][PubMed]
  • 10. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007; 13(8): 807-15[DOI][PubMed]
  • 11. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81[DOI][PubMed]
  • 12. Guo Y, Wang L, Lei J, Xu J, Han L. Antimicrobial and Antibiofilm Activity of Human Cationic Antibacterial Peptide (LL-37) and Its Analogs Against Pan-Drug-Resistant Acinetobacter baumannii. Jundishapur J Microbiol. 2017; 10(3)[DOI]
  • 13. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005; 88(2): 412-9[DOI][PubMed]
  • 14. Garnacho-Montero J, Amaya-Villar R, Ferrandiz-Millon C, Diaz-Martin A, Lopez-Sanchez JM, Gutierrez-Pizarraya A. Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia. Expert Rev Anti Infect Ther. 2015; 13(6): 769-77[DOI][PubMed]
  • 15. Steffen H, Rieg S, Wiedemann I, Kalbacher H, Deeg M, Sahl HG, et al. Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother. 2006; 50(8): 2608-20[DOI][PubMed]
  • 16. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother. 1999; 43(4): 782-8[PubMed]
  • 17. Cai Y, Lim TP, Teo JQ, Sasikala S, Chan EC, Hong YJ, et al. Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model. Antimicrob Agents Chemother. 2017; 61(1)[DOI][PubMed]
  • 18. Bulitta JB, Yang JC, Yohonn L, Ly NS, Brown SV, D'Hondt RE, et al. Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model. Antimicrob Agents Chemother. 2010; 54(5): 2051-62[DOI][PubMed]
  • 19. Rieg S, Garbe C, Sauer B, Kalbacher H, Schittek B. Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol. 2004; 151(3): 534-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments